Assessment of COVID-19's Effect on the Global RNAi Technology Market 2020-2024 | Adoption Of RNAi Technology For Undruggable Targets to Augment Growth | Technavio

Technavio has been monitoring the global RNAi technology market and it is poised to grow by $1.96 bn during 2020-2024, progressing at a CAGR of over 22% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200623005728/en/

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals Inc., Bio-Rad Laboratories Inc., Dicerna Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Horizon Discovery Group Plc, Merck KGaA, QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

The adoption of RNAi technology for undruggable targets has been instrumental in driving the growth of the market.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. https://www.technavio.com/report/report/RNAi-technology-market-industry-analysis

RNAi Technology Market 2020-2024: Segmentation

RNAi Technology Market is segmented as below:

• Application
  • Cancer
  • Infectious Diseases
  • Ophthalmic Diseases
  • Genetic Diseases
  • Other Diseases
• Geographic Landscape
  • Asia
  • Europe
  • North America
  • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40311

RNAi Technology Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The RNAi technology market report covers the following areas:

• RNAi Technology Market Size
• RNAi Technology Market Trends
• RNAi Technology Market Industry Analysis

This study identifies recent advances in whole-genome RNAi screening as one of the prime reasons driving the RNAi technology market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

RNAi Technology Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist RNAi technology market growth during the next five years
• Estimation of the RNAi technology market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the RNAi technology market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of RNAi technology market vendors

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value Chain Analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

• Market segmentation by application
• Comparison by application
• Cancer - Market size and forecast 2019-2024
• Infectious diseases - Market size and forecast 2019-2024
• Ophthalmic diseases - Market size and forecast 2019-2024
• Genetic diseases - Market size and forecast 2019-2024
• Other diseases - Market size and forecast 2019-2024
• Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Growing commercial approvals of RNAi therapy
• Recent advances in whole-genome RNAi screening
• Growing demand for personalized targeted RNAi therapy for cancer

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Alnylam Pharmaceuticals Inc.
• Arbutus Biopharma Corp.
• Arrowhead Pharmaceuticals Inc.
• Bio-Rad Laboratories Inc.
• Dicerna Pharmaceuticals Inc.
• F. Hoffmann-La Roche Ltd.
• Horizon Discovery Group Plc
• Merck KGaA
• QIAGEN NV
• Thermo Fisher Scientific Inc.

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200623005728/en/